Clinical trial
Post-Marketing Database Study for Rivaroxaban in Patients With Pediatric VTE
NCT06278051 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Marketing Database Study for Rivaroxaban in Patients With Pediatric VTE
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 19, 2024
- Completion date
- November 11, 2024
- Enrollment
- 320 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.